Logo image
Pathogenesis and Treatment of Usher Syndrome Type IIA
Journal article   Open access   Peer reviewed

Pathogenesis and Treatment of Usher Syndrome Type IIA

K. Zaw, L.S. Carvalho, M.T. Aung-Htut, S. Fletcher, S.D. Wilton, F.K. Chen and S. McLenachan
Asia-Pacific Journal of Ophthalmology, Vol.11(4), pp.369-379
2022
pdf
Usher_Syndrome_Type.8.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Usher syndrome (USH) is the most common form of deaf-blindness, with an estimated prevalence of 4.4 to 16.6 per 100,000 people worldwide. The most common form of USH is type IIA (USH2A), which is caused by homozygous or compound heterozygous mutations in the USH2A gene and accounts for around half of all USH cases. USH2A patients show moderate to severe hearing loss from birth, with diagnosis of retinitis pigmentosa in the second decade of life and variable vestibular involvement. Although hearing aids or cochlear implants can provide some mitigation of hearing deficits, there are currently no treatments aimed at preventing or restoring vision loss in USH2A patients. In this review, we first provide an overview of the molecular biology of the USH2A gene and its protein isoforms, which include a transmembrane protein (TM usherin) and an extracellular protein (EC usherin). The role of these proteins in the inner ear and retina and their impact on the pathogenesis of USH2A is discussed. We review animal cell-derived and patient cell-derived models currently used in USH2A research and conclude with an overview of potential treatment strategies currently in preclinical development and clinical trials.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

326 File views/ downloads
118 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.36 Ophthalmology
1.36.212 Genetic Retinopathies
Web Of Science research areas
Ophthalmology
ESI research areas
Clinical Medicine
Logo image